Synapse Open Synapse
Biology

In the hunt for reverse merger targets, Caribou could be prized game

BioPharma Dive · · 4 min read

The struggling cell therapy developer is exploring strategic alternatives, which, among other characteristics, make it a likely candidate to receive reverse merger interest.

Latest from BioPharma Dive